A Berkeley Lab spin-out, Newomics is creating blood-based assays for diabetes diagnosis and management, and for the monitoring of environmental toxins, among other health care applications. The core technology, a multi-nozzle emitter array (MEA) for mass spectrometry, was developed by Newomics founder and president Daojing Wang, a guest scientist in Biological Systems and Engineering (BSE), while he was in the Lab’s Life Sciences Division (now part of the Biosciences Area). Collaborators on the emitter technology included Pan Mao, formerly in Life Sciences, and Peidong Yang in the Materials Sciences Division. Read more in the Berkeley Lab News Center.
Three MBIB Scientists Named to the National Academy of Sciences
Three scientists affiliated with the Molecular Biophysics & Integrated Bioimaging Division – Robert Glaeser, Krishna Niyogi, and Susan Marqusee – were among four Lawrence Berkeley National Laboratory (Berkeley Lab)-affiliated researchers elected as members to the National Academy of Sciences (NAS) this week. The election to the NAS recognizes their distinguished and continuing achievements in original research.
Was this page useful?
Send
